Representation of Nucleai in raising $33 million during round B

24 March, 2022

Kobi Ben Chitrit, Liron Hacohen and Nitzan Fischer Conforti represented Nucleai in its raising of $33 million in Round B jointly led by Section 32 and Sanofi Ventures.

The company plans to use the new funding to further develop its drug discovery platform and expand its commercial operations to biopharmaceutical companies and contract research organizations.

Read full article >>

Want to know more?
Contact us

Shiri Menache

Head of Marketing and Business Development

Matan Bar-Nir

Press Officer, OH! PR